Are you Dr. Coughlin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
34th & Civic Center Blvd
Children's Hospital Of Philadelphia
Philadelphia, PA 19104Phone+1 215-590-1000Fax+1 215-561-0959- Is this information wrong?
Summary
- Dr. Christina Coughlin, MD is a pediatric hematologist/oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2001 - 2004
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1999 - 2001
- Perelman School of Medicine at the University of PennsylvaniaClass of 1999
Certifications & Licensure
- PA State Medical License 2001 - 2014
Clinical Trials
- RTX-240 Monotherapy and in Combination With Pembrolizumab Start of enrollment: 2020 May 06
Publications & Presentations
PubMed
- 46 citationsA First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid TumorsLuis A. Diaz, Christina M. Coughlin, Susan C. Weil, Jean Fishel, Mrinal M. Gounder, Susan Lawrence, Nilofer S. Azad, Daniel J. O'Shannessy, Luigi Grasso, Jason Wustner...> ;Clinical Cancer Research. 2015 Mar 15
- 56 citationsCD40-Activated B Cell Cancer Vaccine Improves Second Clinical Remission and Survival in Privately Owned Dogs with Non-Hodgkin's LymphomaKarin U. Sorenmo, Erika L. Krick, Christina M. Coughlin, Beth Overley, Thomas P. Gregor, Robert H. Vonderheide, Nicola J. Mason> ;Plos One. 2011 Aug 31
- 17 citationsApproaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapyChristina Marie Coughlin, Daniel S. Johnston, Andrew Strahs, Michael E. Burczynski, Sarah S. Bacus, Jason Hill, Jay Feingold, Charles Zacharchuk, Anna Berkenblit> ;Breast Cancer Research and Treatment. 2010 Aug 28
- Join now to see all
Press Mentions
- CytoImmune Therapeutics Appoints Remus Vezan, M.D., Ph.D., as Chief Medical OfficerSeptember 7th, 2022
- CytoImmune to Present New Preclinical Data Highlighting Potential of Novel TRACK-NK Cell Therapies as Treatments for Both Solid Tumors and Hematologic MalignanciesMarch 8th, 2022
- City of Hope and CytoImmune Announce Study Demonstrating Novel Off-the-Shelf Chimeric Antigen Receptor (CAR) Natural Killer (NK) Cell-Based Therapy Against Pancreatic CancerJanuary 18th, 2022
- Join now to see all